{"chunk_id": "The-Pregnancy-and-Lactation-Labeling-Rule-(PDF---656KB)__chunk_21", "source": "The-Pregnancy-and-Lactation-Labeling-Rule-(PDF---656KB)", "text": "rm a drug-associated risk of \nmajor birth defects or miscarriage.  In animal reproduction studies, oral \nadministration of [drugname] to pregnant rats and rabbits during the \nperiod of organogenesis at doses up to 40 and 20 times the maximum \nrecommended human dose (MRHD), respectively, resulted in decreased \nfetal body weight gain and delayed skeletal ossification but no teratogenic \neffects were observed. Decreased fetal body weight and delayed skeletal \nossification were not observed at doses"}